Replies to post #138777 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

No proof reported in the medical literature that Sigma-1 upregulation has any demonstrable clinical benefit in humans. IMO, partnership highly unlikely without human efficacy data from late stage trials. Bar is higher due to extraordinary difficulty of treating CNS conditions and failure after failure of promising approaches.

[ExtremelyBullishZig]

The company better get into a partnership soon because you need that to happen for your own investment purposes or because the company needs to do that to succeed?